-
| Exchange | NASDAQ |
|---|---|
| CurrencyCode | USD |
| ISIN | US23126K1060 |
| Sector | Healthcare |
| Industry | Biotechnology |
| Beta | nan |
|---|---|
| Market Cap | 8M |
| PE Ratio | None |
| Target Price | None |
| Dividend Yield | None |
Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients suffering from inflammatory diseases. It develops Phyto-N for various therapeutic areas, including ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, and gout. The company was formerly known as Fordman Pharma Inc. and changed its name to Curanex Pharmaceuticals Inc in November 2023. Curanex Pharmaceuticals Inc was founded in 1996 and is headquartered in Jericho, New York.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for CURX using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026